{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["21(1)"],"submitter":["Ye Q"],"funding":["Chu-Tse Wu Foundation for Science and Technology"],"journal":["Trials"],"pagination":["520"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7290137"],"repository":["biostudies-literature"],"pubmed_title":["Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II)."],"pmcid":["PMC7290137"],"pubmed_authors":["Xia X","Xia ZE","Wu B","Wang H","Wu CT","Yehenala J","Zhao Y","Liu Z","Ye Q","He Y","Zhang Z","Zhou C","Wang S","Zhou G","Hu K"],"additional_accession":[]},"is_claimable":false,"name":"Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).","description":null,"dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Jun","modification":"2026-05-04T12:58:14.676Z","creation":"2022-02-11T10:40:39.752Z"},"accession":"S-EPMC7290137","cross_references":{"pubmed":["32532356"],"doi":["10.1186/s13063-020-04380-5"]}}